Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Arch Biopartners Inc
V.ARCH
Alternate Symbol(s):
ACHFF
Technology
Scientific & Technical Instruments
Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is...
LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:ARCH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Jul 16, 2021 11:07am
Huge Volume
Arch has received : -6.7 million grant to conduct the Phase 2 trial -750k to conduct preclinical trials on inflammation both of these are for Metablok The market can't stay
...more
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Jul 14, 2021 7:59am
NEWS! CIHR Grant Metablok
TORONTO, July 14, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating
...more
(2)
•••
2019champs
X
View Profile
View Bullboard History
Post by
2019champs
on Jul 13, 2021 5:36pm
Results should be no later than end of July
The team has been on point with everything and has been very careful with everything they do. Always under promising and over delivering. Data should be no later than end of July. Excited!
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jul 13, 2021 11:49am
RE:RE:July news
Actually did a word search on the last News bit for "July" and found this: "The Phase II trial team continues to work on preparing, reconciling and closing the patient data base to
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jul 13, 2021 11:46am
RE:July news
Oddly enough I was trying to find out the same thing and in the few minutes I could spare, found nothing. Time to contact the company. I'll keep you posted.
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Post by
stocksarefun
on Jul 13, 2021 9:09am
July news
Does anyone have a beat on mid july, or end of july, for phase 2 results?? The inactivity and lack of volume needs to turn soon
(2)
•••
2019champs
X
View Profile
View Bullboard History
Post by
2019champs
on Jun 29, 2021 4:31pm
We are just weeks away from phase 2 results
July is going to be a great month for us longs! Have a good feeling.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jun 24, 2021 9:09am
RE:RE:RE:RE:RE:RE:RE:RE:Who is shorting????
I hear you Champ. I added more. Universities and Multi-Government funding this is not a P&D. Stock is way undervalued. Looking forward to July.
(2)
•••
2019champs
X
View Profile
View Bullboard History
Comment by
2019champs
on Jun 21, 2021 9:13pm
RE:RE:RE:RE:RE:RE:RE:Who is shorting????
Far from a pump and dump. Have you even researched the company?
(2)
•••
2019champs
X
View Profile
View Bullboard History
Comment by
2019champs
on Jun 21, 2021 8:57pm
RE:RE:RE:RE:RE:RE:Who is shorting????
The seller is definitely anmoying, but it's also an opportunity to buy this stock at a heavy discount. Without this big seller, this would be trading north of $2 easily at this point. I add every
...more
(2)
•••
williepoker
X
View Profile
View Bullboard History
Comment by
williepoker
on Jun 21, 2021 4:27pm
RE:RE:RE:RE:RE:RE:Who is shorting????
Cb27743 Pump and dump?
(4)
•••
Cb27743
X
View Profile
View Bullboard History
Comment by
Cb27743
on Jun 21, 2021 3:18pm
RE:RE:RE:RE:RE:Who is shorting????
Feeling the frustration, the momentum killer/seller is annoying af. If phase 2 results are positive with news of a fast track trial, this will blast off IMO. Would be even better in the future if they
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jun 21, 2021 9:57am
RE:RE:RE:RE:Who is shorting????
We are a month or 6 weeks away from results. Volume is low and picks up when some new "good" news comes out. I don't think and algo is trading this stock and short position is non
...more
(2)
•••
2019champs
X
View Profile
View Bullboard History
Comment by
2019champs
on Jun 18, 2021 11:36am
RE:RE:RE:Who is shorting????
I'm hoping it's some stupid algo shorting. The squeeze would be nice.
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income